{"id":455608,"date":"2026-02-08T03:02:10","date_gmt":"2026-02-08T03:02:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/455608\/"},"modified":"2026-02-08T03:02:10","modified_gmt":"2026-02-08T03:02:10","slug":"hims-hers-wont-sell-compounded-version-of-novos-obesity-pill","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/455608\/","title":{"rendered":"Hims & Hers won’t sell compounded version of Novo\u2019s obesity pill"},"content":{"rendered":"

Hims & Hers said Saturday it will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk\u2019s obesity pill on its telehealth platform, after health officials called for an investigation<\/a> of the company for potentially violating federal law.<\/p>\n

Hims launched the compounded drug earlier this week at $49 month. That prompted immediate backlash<\/a> from Novo, which had launched the pill, the oral version of its injectable Wegovy treatment, last month at $149 to $299 a month. The mass production of copies of a brand-name drug is typically only allowed when the drug is in shortage.\u00a0<\/p>\n

\t\t\t\"\"\t\t<\/p>\n

\t\t\t\t\"\"\/
\n\t\t\t\tSTAT Plus: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy<\/a><\/p>\n

Soon after, the Food and Drug Administration said it would take \u201cdecisive steps\u201d to thwart companies such as Hims that are mass marketing unapproved, compounded versions of GLP-1 drugs. Then on Friday, the Department of Health and Human Services asked the Department of Justice to investigate Hims.<\/p>\n

STAT+ Exclusive Story<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\"STAT+\"\/<\/p>\n

\t\t\t\t\t
\n\t\t\t\t\t\t\"STAT+\"\/
\n\t\t\t\t\t<\/a><\/p>\n

\t\t\t\tThis article is exclusive to STAT+ subscribers
\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\t\t\tIndividual plans<\/p>\n

\t\t\t\t\t\tGroup plans<\/p>\n

\t\t\t\tView All Plans<\/a><\/p>\n

\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n

\t\t\t\t\tSubscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Hims & Hers said Saturday it will stop selling what it claims to be a cheaper, compounded version…\n","protected":false},"author":2,"featured_media":451470,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[28,986,247,248],"class_list":["post-455608","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-business","tag-obesity","tag-pharmaceuticals","tag-stat"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/455608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=455608"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/455608\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/451470"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=455608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=455608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=455608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}